Cargando…

Albumin as a Biomaterial and Therapeutic Agent in Regenerative Medicine

Albumin is a constitutional plasma protein, with well-known biological functions, e.g., a nutrient for stem cells in culture. However, albumin is underutilized as a biomaterial in regenerative medicine. This review summarizes the advanced therapeutic uses of albumin, focusing on novel compositions t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuten Pella, Olga, Hornyák, István, Horváthy, Dénes, Fodor, Eszter, Nehrer, Stefan, Lacza, Zsombor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502107/
https://www.ncbi.nlm.nih.gov/pubmed/36142472
http://dx.doi.org/10.3390/ijms231810557
_version_ 1784795626091839488
author Kuten Pella, Olga
Hornyák, István
Horváthy, Dénes
Fodor, Eszter
Nehrer, Stefan
Lacza, Zsombor
author_facet Kuten Pella, Olga
Hornyák, István
Horváthy, Dénes
Fodor, Eszter
Nehrer, Stefan
Lacza, Zsombor
author_sort Kuten Pella, Olga
collection PubMed
description Albumin is a constitutional plasma protein, with well-known biological functions, e.g., a nutrient for stem cells in culture. However, albumin is underutilized as a biomaterial in regenerative medicine. This review summarizes the advanced therapeutic uses of albumin, focusing on novel compositions that take advantage of the excellent regenerative potential of this protein. Albumin coating can be used for enhancing the biocompatibility of various types of implants, such as bone grafts or sutures. Albumin is mainly known as an anti-attachment protein; however, using it on implantable surfaces is just the opposite: it enhances stem cell adhesion and proliferation. The anticoagulant, antimicrobial and anti-inflammatory properties of albumin allow fine-tuning of the biological reaction to implantable tissue-engineering constructs. Another potential use is combining albumin with natural or synthetic materials that results in novel composites suitable for cardiac, neural, hard and soft tissue engineering. Recent advances in materials have made it possible to electrospin the globular albumin protein, opening up new possibilities for albumin-based scaffolds for cell therapy. Several described technologies have already entered the clinical phase, making good use of the excellent biological, but also regulatory, manufacturing and clinical features of serum albumin.
format Online
Article
Text
id pubmed-9502107
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95021072022-09-24 Albumin as a Biomaterial and Therapeutic Agent in Regenerative Medicine Kuten Pella, Olga Hornyák, István Horváthy, Dénes Fodor, Eszter Nehrer, Stefan Lacza, Zsombor Int J Mol Sci Review Albumin is a constitutional plasma protein, with well-known biological functions, e.g., a nutrient for stem cells in culture. However, albumin is underutilized as a biomaterial in regenerative medicine. This review summarizes the advanced therapeutic uses of albumin, focusing on novel compositions that take advantage of the excellent regenerative potential of this protein. Albumin coating can be used for enhancing the biocompatibility of various types of implants, such as bone grafts or sutures. Albumin is mainly known as an anti-attachment protein; however, using it on implantable surfaces is just the opposite: it enhances stem cell adhesion and proliferation. The anticoagulant, antimicrobial and anti-inflammatory properties of albumin allow fine-tuning of the biological reaction to implantable tissue-engineering constructs. Another potential use is combining albumin with natural or synthetic materials that results in novel composites suitable for cardiac, neural, hard and soft tissue engineering. Recent advances in materials have made it possible to electrospin the globular albumin protein, opening up new possibilities for albumin-based scaffolds for cell therapy. Several described technologies have already entered the clinical phase, making good use of the excellent biological, but also regulatory, manufacturing and clinical features of serum albumin. MDPI 2022-09-12 /pmc/articles/PMC9502107/ /pubmed/36142472 http://dx.doi.org/10.3390/ijms231810557 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kuten Pella, Olga
Hornyák, István
Horváthy, Dénes
Fodor, Eszter
Nehrer, Stefan
Lacza, Zsombor
Albumin as a Biomaterial and Therapeutic Agent in Regenerative Medicine
title Albumin as a Biomaterial and Therapeutic Agent in Regenerative Medicine
title_full Albumin as a Biomaterial and Therapeutic Agent in Regenerative Medicine
title_fullStr Albumin as a Biomaterial and Therapeutic Agent in Regenerative Medicine
title_full_unstemmed Albumin as a Biomaterial and Therapeutic Agent in Regenerative Medicine
title_short Albumin as a Biomaterial and Therapeutic Agent in Regenerative Medicine
title_sort albumin as a biomaterial and therapeutic agent in regenerative medicine
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502107/
https://www.ncbi.nlm.nih.gov/pubmed/36142472
http://dx.doi.org/10.3390/ijms231810557
work_keys_str_mv AT kutenpellaolga albuminasabiomaterialandtherapeuticagentinregenerativemedicine
AT hornyakistvan albuminasabiomaterialandtherapeuticagentinregenerativemedicine
AT horvathydenes albuminasabiomaterialandtherapeuticagentinregenerativemedicine
AT fodoreszter albuminasabiomaterialandtherapeuticagentinregenerativemedicine
AT nehrerstefan albuminasabiomaterialandtherapeuticagentinregenerativemedicine
AT laczazsombor albuminasabiomaterialandtherapeuticagentinregenerativemedicine